News & Articles
Selected Filters:
Quantitative proteomics advances disease modeling and drug development
Learn how Inotiv’s proteomics services are helping researchers gain deeper insights into drug target systems, to better select disease models, and quantify pathology data
First-of-its-kind 3D bone marrow model advances blood cancer research
Crown Bioscience’s in vitro model offers a physiologically relevant tool to evaluate drug efficacy for hematological diseases
Introducing the iQue 5 HTS Platform: Unmatched speed and flexibility for high-throughput cytometry screening
Intuitive software supports 24 hours of continuous runtime and easy analysis of complex high-throughput datasets
Emulate launches AVA emulation system to accelerate drug development with first-of-its-kind high-throughput organ-chip platform
Built-in incubation, automated imaging, and AI-ready data generation deliver in vivo fidelity at scale
Standardizing metabolomics advances biomarker discovery
Discover how prioritizing reproducibility and method validation can empower researchers to unlock the full potential of metabolomics in advancing biomarker discovery and drug development
Life Sciences and General Lab Scientists’ Choice Awards 2025 winners announced
Logos Biosystems, SPT Labtech and BMG LABTECH among those recognized
ELRIG announces Prof. Rory Johnson and Dr. Shalini Andersson as Keynote Speakers at Therapeutic Oligonucleotides 2025
Therapeutic Oligonucleotides 2025: Drugging the Undruggable takes place at AstraZeneca in Gothenburg, Sweden from May 14–15
HORIBA expands instrument offerings to support the drug pipeline from discovery to manufacturing
Providing a portfolio of instruments tailored to meet the rigorous demands of the pharmaceutical industry
Drug Discovery & Development Scientists’ Choice Award 2025 winners announced
Agilent, Tecan, and Cytiva among those recognized
Key highlights to expect from SLAS 2025
Set to take place in San Diego, California, from January 25–29, SLAS2025 International Conference & Exhibition promises to be an unmissable event for professionals in laboratory science, automation, and drug discovery
Getting organoids into the clinic
Dr. Christian Regenbrecht discusses the power of patient-derived tumor organoids and their promising future in clinical practice
Patient-derived organoids open doors to personalized medicine
Dr. Kangxin He at Zhejiang University has developed a high-throughput drug screening platform using patient-derived organoids to identify the best treatment for individual patients
Drug Discovery & Development Scientists’ Choice Awards winners announced at SLAS2024
Agilent Technologies, Thermo Fisher Scientific, and Tecan among those recognized
SCIEX launches high-throughput screening solutions at SLAS2024
The Echo MS+ system unlocks enhanced high-throughput screening capability
Vote for the Best New Drug Discovery & Development Product in the Scientists’ Choice Awards
For the chance to win a $500 Amazon Gift Card (or equivalent currency) cast your vote for the new product that has made the most difference to research
Nominate your favorite new lab product of 2023 for a Scientists’ Choice Award
Tell us which new products have had the biggest impact on your lab work for a chance to win a $500 Amazon.com Gift Card (or equivalent currency)
SelectScience introduces its new merch
The brand-new SelectScience T-shirts and EXCLUSIVE festive sweater are here, find out how you could win one
Streamlining compound management with a fully automated workstation
How a biopharmaceutical company successfully brought its compound management in-house with the help of automation
SLAS2023: Lab automation news round-up
Catch up on the latest lab automation hot topics and new technology from SLAS2023
How new biophysical characterization technologies are advancing early screening strategies
An expert view on the latest trends in label-free biophysical characterization technology
5 cell and gene therapy webinars to watch on demand
Expert webinars to explore the latest research and challenges in cell and gene therapy development
Akoya Biosciences launches PhenoCode Signature Panels to accelerate development of predictive biomarkers for cancer immunotherapy
Each panel focuses on distinct areas of tumor biology and response to therapy which are of greatest interest to translational and clinical researchers
























